Oncotarget

Research Papers:

By recruiting HDAC1, MORC2 suppresses p21 Waf1/Cip1 in gastric cancer

Qing Zhang _, Yanyan Song, Wei Chen, Xiaohui Wang, Zhifeng Miao, Liu Cao, Feng Li and Guiling Wang

PDF  |  HTML  |  Supplementary Files  |  How to cite  |  Order a Reprint

Oncotarget. 2015; 6:16461-16470. https://doi.org/10.18632/oncotarget.3889

Metrics: PDF 1251 views  |   HTML 1414 views  |   ?  


Abstract

Qing Zhang1, Yanyan Song1, Wei Chen1, Xiaohui Wang1, Zhifeng Miao2, Liu Cao1, Feng Li1, Guiling Wang1

1Department of Cell Biology, Key Laboratory of Cell Biology, Ministry of Public Health, and Key Laboratory of Medical Cell Biology, Ministry of Education, China Medical University, Shenyang, China

2Department of Surgical Oncology and General Surgery, First Hospital of China Medical University, Shenyang, China

Correspondence to:

Guiling Wang, e-mail: wanggl@mail.cmu.edu.cn

Feng Li, e-mail: fli@mail.cmu.edu.cn

Keywords: MORC2, p21, HDAC1, cell proliferation, gastric cancer

Received: January 21, 2015     Accepted: April 25, 2015     Published: May 08, 2015

ABSTRACT

Microrchidia (MORC) family CW-type zinc-finger 2 (MORC2) regulates chromatin remodeling during the DNA-damage response, represses gene transcription, promotes lipogenesis. Here, we found that MORC2 down-regulated p21 by recruiting HDAC1 to the p21 promoter, in a p53-independent manner. MORC2-mediated down-regulation of p21 in turn promoted cell cycle progression in gastric cancer cells. Furthermore, MORC2 expression correlated negatively with p21 expression in gastric tumors in patients. We suggest that MORC2 may be a potential therapeutic target in cancer.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 3889